Patrik Jeanmonod - Feb 24, 2023 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Signature
/s/ Valerie Barnett, Attorney-in-Fact for Patrik Jeanmonod
Stock symbol
CTKB
Transactions as of
Feb 24, 2023
Transactions value $
-$33,150
Form type
4
Date filed
2/28/2023, 05:48 PM
Previous filing
Feb 23, 2023
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Sale -$33.2K -3K -2.56% $11.05 114K Feb 24, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022, as last modified on September 13, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.